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ABSTRACT Ca2 homeostasis requires balanced up-
take and extrusion, and dysregulation leads to disease.
TRPV6 channels are homeostasis regulators, are up-
regulated in certain cancers, and show an unusual allele-
specific evolution in humans. To understand how Ca2
uptake can be adapted to changes in metabolic status,
we investigate regulation of Ca2-influx by ATP and
phosphorylation. We show that ATP binds to TRPV6,
reduces whole-cell current increments, and prevents
channel rundown with an EC50 of 380 M. By using
both biochemical binding studies and patch-clamp anal-
yses of wild-type and mutant channels, we have mapped
one relevant site for regulation by ATP to residues
within the ankyrin repeat domain (ARD) and identify an
additional C-terminal binding region. Stimulation of
PKC largely prevented the effects of ATP. This regula-
tion requires PKCII and defined phosphorylation sites
within the ARD and the C-terminus. Both regulatory
sites act synergistically to constitute a novel mechanism
by which ATP stabilizes channel activity and acts as a
metabolic switch for Ca2 influx. Decreases in ATP
concentration or activation of PKCII disable regula-
tion of the channels by ATP, rendering them more
susceptible to inactivation and rundown and preventing
Ca2 overload.—Al-Ansary, D., Bogeski, I., Disteldorf,
B. M. J., Becherer, U., Niemeyer, B. A. ATP modulates
Ca2 uptake by TRPV6 and is counteracted by isoform-
specific phosphorylation. FASEB J. 24, 000–000 (2010).
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Transcellular Ca2 transport is a highly energy-
consuming process because Ca2 efflux has to be
accomplished against an 10,000-fold concentration
gradient and an 40–60 mV membrane potential
difference. Ca2 influx, in contrast, follows this electro-
chemical gradient and must be tightly regulated to
avoid toxic Ca2 overload. TRPV5 and TRPV6 are
highly selective for Ca2, and their vitamin D-regulated
expression in Ca2-transporting epithelia (e.g., placen-
tal tissues and epithelial cells of the intestine and
kidney) and in exocrine tissues such as pancreatic
acinar and salivary gland cells (TRPV6) make them
candidates for selective Ca2 entry (1, 2). In expression
systems they are constitutively active at low intracellular
Ca2 concentrations (3–5). Ca2-dependent negative
feedback regulation has been studied in detail for both
channels (6, 7). TRPV6 shows both a rapid, Ca2-
dependent but calmodulin-independent regulation
with involvement of the first intracellular loop (8, 9)
and a slower calmodulin-dependent regulation that
involves binding of calmodulin to the distal C-terminal
region of the protein (10, 11). Depletion of PIP2 also
interferes with Ca2-dependent inactivation (12) and
with permeation block by Mg2, as shown for TRPV5
(13). But are these the signals that keep channels open
if more Ca2 uptake is required? Which regulatory
pathways close the channels when sufficient Ca2 has
been transferred?
Many ion channels and transporters are regulated by
ATP-dependent mechanisms (14–20), but the mecha-
nism and binding sites for Ca2 channels are unknown.
For the capsaicin receptor TRPV1 it has recently been
shown that binding of ATP within its N-terminal
ankyrin repeat domains (ARDs) can prevent capsaicin-
induced tachyphylaxis. Here binding of ATP competes
with binding of calmodulin (21). Although TRPV6
contains a similar number and a related structure of
ARDs as TRPV1, it neither binds calmodulin within its
ARDs nor is the ATP binding pocket of TRPV1 con-
served (21, 22).
TRPV6 also exhibits a highly unusual coupled poly-
morphism within the human population (5): although
the ancestral allele (TRPV6a: R157, V378, T681) is
predominant among African populations, the derived
allele (TRPV6b: C157, M378, and M681) is predomi-
nant in all other tested population groups, suggesting
that this haplotype conferred a temporally or geograph-
ically selective advantage (23). The reason for this
selection has remained elusive, and no obvious differ-
ences in ion channel properties have been found (24).
TRPV6 expression correlates with the invasiveness of
certain cancers such as prostate cancer and may serve as
a prognostic marker for its outcome (25). Whether the
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increased incidence of prostate cancer among African
Americans (26) correlates with the TRPV6 polymor-
phism is unknown. To understand how channels are
regulated by the metabolic status, we investigated the
influence and the mechanism of ATP regulation. Be-
cause ATP is expected to fuel protein kinases and
because the 2 alleles differ in the number of potential
PKC phosphorylation sites, we also focused on the
regulation by protein kinases.
MATERIALS AND METHODS
Cell culture
HEK293 cells (CRL-1573; American Type Culture Collection,
Manassas, VA, USA) and TRPV6 stable cell lines were main-
tained in a 37°C, 5%CO2 humidified incubator in Dulbecco’s
modified Eagle medium (DMEM) containing 10% fetal calf
serum and 4 mM l-glutamine and supplemented with 200 U/ml
penicillin-G-sodium and 100 g/ml streptomycin or hygromy-
cin-b (Invitrogen, Carlsbad, CA, USA), respectively. Cells were
passaged by treatment with trypsin. Stable cell lines were created
from TRPV6a- or -b-expressing vector (pcDNA5/FRT) trans-
fected into Flp-In™-293 cells (Invitrogen) using Superfect
Transfection-Reagent (Qiagen, Valencia, CA, USA). Transient
transfections of constructs cloned into pCAGGS_IRES_EGFP
plasmids were made with Fugene Transfection Reagent (Roche
Diagnostics, Mannheim, Germany). Cells were trypsinized and
seeded at low density after 24 h and recorded from after48 h.
Electrophysiology
TRPV6a (AJ243500) or TRPV6b (AJ243501) stable HEK293
(D11, C3) cells or transiently transfected wild-type or mutant
constructs in pCAGGS-IRES-GFP were used for patch-clamp
recordings. Recordings were performed at room temperature in
the tight-seal whole-cell configuration using electrodes of 2–4
M resistance. Cell capacitance and access resistance were
monitored before each voltage ramp, and measurements were
discarded when  access resistance was5 M. Series resistance
was compensated to 80%. Membrane currents were filtered at
1.5 kHz and digitized at a sampling rate of 5–10 kHz. Currents
were recorded with an EPC-9 patch-clamp amplifier controlled
by Pulse 8.3 software (HEKA Electronics, Lambrecht/Pfalz,
Germany). Immediately after establishing whole-cell configura-
tion, linear voltage ramps from100 to100 mV within 100 ms
were applied every 10 s from a holding potential of 70 mV for
10 or 20 min as indicated. Currents at 80 mV ramp potential
were divided by cell capacitance, normalized (CD/CDmax,
where CDcurrent density), and plotted against time. The
pipette solution contained the following (in mM): 140 cesium
aspartate, 10 EGTA, 10 NaCl, 10 HEPES, and 16 M MgCl2 or 1
mM MgCl2 with 6 mM Na2ATP (pH 7.2 with CsOH). The
resulting free Mg2 concentration of 11 M was kept constant
for the different concentrations of ATP or other nucleotides by
adjusting total [Mg2] using CaBuf software (ftp://ftp.cc.kuleuven.
ac.be/pub/droogmans/cabuf.zip). The bath solution con-
tained the following (in mM): 115 tetraethylammonium
chloride, 10 CsCl, 2.8 KCl, 2 MgCl2, 30 CaCl2, 10 glucose, and
20 HEPES (pH 7.4 with NaOH). ATP concentration-response
curves were fitted by Eq. 1:
Y  base
max base
1 	X1/2 /X
rate
(1)
Statistical analysis was performed using an unpaired,
2-tailed Student’s t test. Values of P  0.05 were
considered significant.
Fluorescence-based Ca2 imaging
Imaging of free intracellular Ca2 concentration ([Ca2]i)
was performed using an Olympus IX 70 inverted microscope
(Olympus Deutschland, Hamburg, Germany) equipped with
an 20 (UApo/ 340, N.A. 0.75) objective, a Polychrome V
Monochromator, and a charge-coupled device camera (TILL
Imago; TILL Photonics, Gra¨felfing, Germany). HEK cells
were loaded with 1 M Fura-2/AM in DMEM growth medium
at 37°C for 15 min in a dark chamber. Images were analyzed
using TILL Vision software. Bath solutions contained (in
mM): 150 NaCl, 2.8 KCl, 1 MgCl2, 1 CaCl2, 20 glucose, and 10
HEPES (pH 7.4 with NaOH) or with 135 NaCl and 10 CaCl2.
In the ATP depletion medium NaCl was reduced to 140 mM,
glucose was substituted by 20 mM deoxyglucose, and 10 mM
sodium azide (NaN3) was added. The absolute intracellular
Ca2-concentration was calculated as described by Grynk-
iewicz et al. (27).
Fluorescence-based H2O2 detection
Intracellular H2O2 was detected with the same equipment
used for Ca2 imaging. HEK cells were loaded with 1 M
CM-H2DCFDA [2,7-dichlorofluorescin (DCF); Invitrogen]
for 30 min at room temperature. DCF fluorescence was
measured at 485 nm excitation and 535 nm emission. GFP
fluorescence was used to detect the transiently transfected
cells.
Site-directed mutagenesis
Quickchange Site-Directed Mutagenesis Kit (Stratagene, La
Jolla, CA, USA) was used to introduce the desired mutations
(namely, R153Q/R154P and R606Q) and to mutate the
potential phosphorylation sites identified by the prosite soft-
ware (http://www.expasy.ch/prosite) or the NetPhosK
(http://www.cbs.dtu.dk/services/NetPhosK/) by replacing
the serine or threonine codons at the specified sites with
alanine codons (S144A, T150A, T298A, T299A, S318A,
T688A, T702A). The mutated fragments were confirmed by
double-stranded sequencing. Unless otherwise noted, muta-
tions were done in the hTRPV6b background.
Cloning and expression of His-tagged proteins
The sequences coding for different fragments of the human
TRPV6 N- and C-termini were PCR amplified from hTRPV6b
cDNA and subcloned into the BamHI or XhoI site of pET19b
vector (10 N-term HIS). The fusion protein covering aa 1-117
was made from mouse TRPV6. Protein expression was carried
out in transformed Escherichia coli BL21 strains. Overnight
cultures were diluted 1:20, grown until an OD600 of 0.5, and
protein production was induced with 100 M of IPTG for 4 h
at 30°C. Cells were pelleted by centrifugation at 6000 g for 15
min, and pellets were initially resuspended in 5 mM imida-
zole, 500 mM NaCl, and 20 mM Tris (pH 7.9). Lysates were
sonicated 3 30 s and centrifuged at 13,000 g for 20 min, and
pellets were resuspended in the above buffer with a repeat of
sonication and centrifugation. The final resuspension buffer
also contained 6 M urea (BBU). Lysates were then incubated
with gentle rotation at 4°C for 1 h and pottered with a
Dounce homogenizer. Finally, lysates were ultracentrifuged at
24,000 g for 25 min at 4°C, and supernatants were incubated
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overnight with Ni-NTA beads (Qiagen). Columns were
washed once with BBU, then with BBU containing 15 mM
imidazole. Proteins were eluted with BBU with 1 M imidazole.
The integrity and size of the purified proteins were checked
by Coomassie-stained PAGE gels, and protein concentration
was determined by BCA (Pierce, Rockford, IL, USA). For
native protein expression, ARD (42–266) and CT (633–725)
were cloned into a modified pET21b vector (28), and bacteria
were induced at an OD600 of 0.5 with 75 M IPTG for 16 h at
25°C. Pellets were resuspended in 20 mM Tris-HCL (pH 8.0),
300 mM NaCl, 20 mM Imidazole, 1 mM PMSF, 0.1% Triton-
X-100, 0.2 mg/ml lysozyme, 50 g/ml RNase, and 25 g/ml
DNase and treated as above. The cleared (20 min at 30,000 g)
lysates were incubated with Ni-NTA beads for 2 h at 4°C and
washed with 20 mM Tris-HCl (pH 8), 300 mM NaCl, and 20 mM
imidazole. For elution, imidazole was increased to 200 mM.
ATP-agarose binding
Different His-tagged proteins (40 g) were diluted to 900 l
with binding buffer: 10 mM Tris (pH 7.5), 50 mM NaCl, 1 mM
DTT (no DTT for native proteins), and 0.15% w/v dodecyl-
-D-maltopyranoside (see also ref. 21) with or without 6/15
mM ATP or adenosine, and incubated at 4°C first for 20 min,
then with 75 l of prewashed 50% slurry of ATP-agarose
(bound by a C6-spacer to C-8 of ATP; Sigma-Aldrich, St Louis,
MO, USA) for 2 h with gentle rotation. Afterward, beads were
sedimented, washed 4 times with 1 ml binding buffer, and
resuspended in the corresponding loading buffer, depending
on the type of gel and buffer used. Probes were denatured at
37°C for 30 min and separated by 15% SDS-PAGE or 10–20%
TRIS/Tricine PAGE. Samples were divided, and gels were
either incubated with Coomassie-stain or used to blot the
proteins to nitrocellulose or PVDF membranes followed by
detection with our own affinity purified antibody against the
His-tag. Binding experiments were repeated at least 3 times
also with different batches of expressed protein.
RESULTS
ATP prevents rundown of TRPV6 Ca2 currents
To investigate regulation of TRPV6 we recorded either
from a stable TRPV6b-expressing cell line that was
generated by targeted insertion or from HEK293 cells
48 h after transient transfection. Cells were subjected to
voltage ramps at 0.1 Hz for 20 min, and currents were
analyzed at 80 mV ramp potential. Figure 1A shows
the development of inwardly rectifying Ca2 currents
over time. In the absence of ATP, inward currents reach
their maximum within the first 2 min, then decrease
continuously to 30% after 20 min. To quantitate this
rundown, we defined the remaining current densities
(%REM) at 20 min as percentage of maximum (Fig.
1B) and analyzed the time to half-maximal activation
(t1/2, Fig. 1C). Figure 1D shows the mean inwardly
rectifying current-voltage relationships for TRPV6b at
different time points as indicated in Fig. 1A. To test
whether rundown can be reduced by ATP, we included
Figure 1. ATP prevents rundown of TRPV6 Ca2 currents. A) Whole-cell inward current density (CD) measured from
TRPV6b-expressing cells at 80 mV ramp potential normalized to CDmax and plotted vs. recording time. Traces are averages
of normalized CD over time with pipette solution without ATP (gray) or containing 6 mM Na2ATP (black) and both containing
11 M free Mg2. Error bars represent means  se. B) Percentage remaining current (%REM) after 20 min in the absence
(gray) and presence (black) of ATP. Numbers on bars represent number of cells. C) Quantification of the time to half-maximal
activation in the absence and presence of ATP. D) Average I/V relationships immediately after break-in (1), at 2 min (2), and
after 20 min (3), showing typical inwardly rectifying TRPV6b currents in the absence of ATP. E) Sample I/V relationships as
described in D but in the presence of ATP. F) Top panel: Fura-2/AM loaded HEK-TRPV6b cells show a transient increase in
Ca2 when extracellular Ca2 is increased to 10 mM. Influx can again be evoked after 1 h if cells are briefly exposed to 1 mM
Ca2 bath before the switch. Middle panel: Same protocol as above, but bath solution after the first transient includes 20 mM
deoxyglucose instead of glucose and 10 mM sodium azide. Bottom panel: HEK wild-type cells before and after depletion. Traces
are averages of  100 cells for HEK-TRPV6 and 75 cells for HEK wild type.
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6 mM Na2ATP in the recording pipette and clamped
[Mg2]i to that of the control solution (11 M).
Because [Mg2]i is below the IC50 for Mg
2 block of
the pore (29), we can exclude confounding influences
on pore properties. Inclusion of ATP led to altered
kinetics of current development (Fig. 1A): initial cur-
rent densities were reduced to 16.3  3.4 pA/pF
(n15) compared to 39.7  15 pA/pF (n11,
P0.5), and subsequent increments in current ampli-
tude were also reduced, leading to current densities
that did not decrease within the recording time (Fig.
1A), thus resulting in 100% REM after 20 min (Fig.
1B). To test whether the initial reduction in current
density was due to an effect of external perfusion of
ATP while approaching the cell with the patch pipette,
we recorded from cells with no ATP in the patch
pipette but locally perfused ATP from a second pipette
immediately before and after break-in. However, initial
current densities were not reduced (41.36.6 pA/pF,
n4), likely excluding activation of purinergic recep-
tors as the cause of current reduction.
Mean IV relationships in the presence of ATP (Fig.
1E) indicate that no other major ATP-induced conduc-
tances were observed with our recording conditions but
revealed a minor decrease in the steepness of inward
rectification. A shift in the same direction is seen in the
absence of ATP when EGTA is replaced by BAPTA
(data not shown), which may indicate a decrease in the
Ca2-dependent feedback mechanism when adding
ATP to the EGTA pipette solution. To exclude the
possibility that ATP is preventing rundown solely by
increasing the fast calcium-buffering capacity of the
pipette solution, we confirmed that ATP still had sig-
nificant effects in the presence of 20 mM BAPTA (data
not shown). Prevention of rundown by ATP has also
been shown in Ca2-free conditions (30). The maximal
current densities for TRPV6b after 20 min with ATP
were 153  11 pA/pF, which were not different when
compared to the maximal current densities without
ATP (16027 pA/pF).
The effects of ATP on both kinetics of current
development and on rundown were also seen with
transient expression of TRPV6b. Rundown and t1/2
were analyzed at 10 min recording time, as transiently
expressing cells were less stable. Whereas in the ab-
sence of ATP the kinetics of current development,
maximal current density, and the degree of rundown
were comparable for transient vs. stable transfected
cells (Supplemental Fig. S1A), in the presence of ATP
the slowdown of current development was also signifi-
cant, but less pronounced than with stable TRPV6
expression (t1/2 5710 vs. 11722 s for transient and
stable expressed TRPV6b, respectively; Supplemental
Fig. S1A, B). Because oxidation has been shown to
modulate binding of ATP to chloride channels (31), we
used the fluorescent indicator DCF to test whether
transient expression influences the redox state of the
cells. Indeed, Supplemental Fig. S1C shows that tran-
siently transfected cells showed higher levels of intra-
cellular oxidants than stable cells. We thus investigated
the influence of oxidants (H2O2) on the time course of
TRPV6 in the stable expression system. Supplemental
Fig. S1D shows that increasing oxidative stress through
addition of H2O2, probably by modifying reactive cys-
teines of TRPV6, leads to larger current increments in
the presence of ATP and can thus explain the faster
current development in cells transiently expressing
TRPV6. However, even in the presence of a strong
oxidant, ATP is still able to prevent rundown (Supple-
mental Fig. S1D). For further analyses, we have focused
on the effects of ATP on the percentage of rundown
(%REM) and compared rundown at 20 min for stable
and at 10 min for transient expression.
To mimic a more physiological condition, we tested
the influence of ATP depletion (32) on Ca2 transients
in unperturbed cells. Figure 1F shows that TRPV6 cells
respond to a change in [Ca2]e with a transient in-
crease in [Ca2]i. This transient increase can again be
evoked after 50 min (Fig. 1F, top panel). However,
when TRPV6 cells are ATP depleted, the second tran-
sient peak is absent (Fig. 1F, middle panel), confirming
that either a sufficient concentration of ATP or of a
metabolite is needed for the ability to respond to
sudden changes in [Ca2]e. HEK cells show a lower
resting Ca2 and do not show a transient increase in
[Ca2]i on exposure to 10 mM [Ca
2]e (Fig. 1F, bottom
panel). Interestingly, in HEK cells, the change back to 1
mM [Ca2]e does not lead to a drop in [Ca
2]i (Fig. 1F,
top panel), which may be due to Ca2-ATPase inactivity at
low resting [Ca2]i (Km 0.4–0.5 M; 33).
Thyagarajan et al. (12) showed that hydrolysis of PIP2
mediated Ca2-induced inactivation of TRPV6 chan-
nels (12). To test the potential involvement of PIP2 in
the ATP effect, we replaced ATP with 50 M diC8PIP2,
which was unable to prevent rundown in the absence of
ATP (Fig. 2A, B). We also included a nonhydrolyzable
ATP analog, AMP-PCP, in the pipette solution. This
analog also prevented rundown and slowed current
development (Fig. 2A, B). Because R599 was identified
as a critical residue responsible for mediating PIP2-
dependent channel activity in TRPV5 (34), we checked
whether this highly conserved arginine mediates the
ATP effect in TRPV6 (R599 in rbTRPV5R606 in
hTRPV6). We mutated R606 to Q and recorded the
transiently expressed mutant in the presence and ab-
sence of ATP. Figure 2C, D shows that ATP is still able
to prevent rundown in the mutant. Together with the
evidence seen in Fig. 2A, the results suggest that ATP
prevents rundown of TRPV6 in a PIP2-independent
manner.
Nucleotide specificity
To further test the specificity of the ATP effect, we
included different nucleotides in the pipette solution at
6 mM each. Figure 3A shows currents over time for
some of the tested nucleotides, and Fig. 3B the percent-
age REM for all nucleotides tested. Although adenosine
and cAMP were unable to prevent rundown, other
phosphorylated nucleotides had intermediate effects,
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with AMP being more potent than GTP and slightly
more potent than UTP, which suggests that both nu-
cleotide moiety and number of negatively charged
phosphate groups are essential (Fig. 3A). To test the
dependence of rundown on the ATP concentration, we
calculated the dose response relationship after record-
ing currents with different free ATP concentrations,
keeping free [Mg2] constant. Figure 3C shows sample
traces of currents with 6, 304, and 609 M and 3.7 mM
free ATP in the pipette solution. Data points were fitted
with a sigmoidal dose-response function of variable
slope, where %REMmax is the maximal remaining cur-
rent obtained after addition of 3.7 mM free ATP, EC50
is the half-maximal concentration of free ATP, and n is
the Hill slope. As shown in Fig. 3D, the mean EC50
obtained from the graph was 378 M free ATP, and the
Hill slope was 4.8. The EC50 value obtained is one order
of magnitude greater than that normally required for a
kinase-mediated phosphorylation reaction (14); how-
ever, we also investigated the crosstalk between run-
down and PKC-mediated phosphorylation.
Regulation by protein kinase C and identification of a
functionally relevant ATP binding site
To measure TRPV6 currents in the presence of ATP
and after activation of protein kinases, we incubated
cells for 1 h with 500 nM PMA in serum-free medium
and then recorded with PMA also present in the bath
solution. Figure 4A shows that incubation with PMA was
able to partially prevent the effects of ATP: Although
ATP was included, current size increased much faster,
reached maximal values within the first 2 min, and
entered rundown (Fig. 4A, B).
Because the ancestral polymorphic allele (TRPV6a)
contains an additional potential PKC phosphorylation
site (SPR157) compared to SPC for TRPV6b, we also
tested the effects of PMA treatment on TRPV6a and
found a slightly more efficient prevention of the ATP
effect (Fig. 4C, D). In the absence of ATP, PMA
treatment had little effect on rundown (Supplemental
Fig. S2A, B). The finding that the polymorphs differ
slightly in the extent of the PMA effect may point
Figure 3. Nucleotide specificity and dose-response curve for ATP. A) Normalized current
density over time in the presence of different intracellular nucleotides at 6 mM. Error bars
represent means  se. B) Quantification of percentage REM for all nucleotides tested.
Asterisks indicate significant differences of percentage REM against the no-added-ATP
control. Numbers on bars represent number of cells. Recordings were obtained in stable
TRPV6b cells. C) Normalized current density over time for selected concentrations of
intracellular free ATP. D) Mean relationship between [free ATP] and the degree of
rundown after 20 min (%REM). Data points (number of cells above) were best fitted to Eq.
1. EC50, ATP concentration at which prevention of rundown is half-maximal; nH, Hill slope.
Figure 2. Effects of PIP2 and a nonhydrolyzable ATP analog on rundown. A) Normalized current density over time in the
absence of ATP (gray trace), in the presence of 50 M diC8PIP2, or in the presence of 6 mM AMP-PCP in TRPV6b stable cell
line. B) Percentage REM for traces in A. C) R606Q mutants retain the ATP effect. Normalized current density over time for
transiently expressed TRPV6_R606Q mutants with and without ATP in the recording pipette. D) Percentage REM after 10 min
recording time; see also Fig. 5B for transiently expressed wild type.
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toward S155 being involved in preventing the ATP
effect. S155, as well as the joint first putative phosphor-
ylation site S144, is located within the ARD in a loop
between repeats 3 and 4 (see ref. 22 for structural
information). We wondered whether phosphorylation
can partially suppress the effects of ATP because of the
charge screening effect of the phosphorylated (nega-
tive) moiety onto nearby positively charged side groups
required for a direct interaction with the phosphate
groups of ATP. If this were so, one would predict that
this region also would contain residues important for
ATP binding. Two positively charged arginine residues
(R153/R154) are in proximity to the S144 phosphory-
lation site and adjacent to the polymorphic phosphor-
ylation site S155 (Fig. 5A). We thus mutated these
residues (RR/QP) and recorded currents in the pres-
ence of 3.7 mM free ATP. As seen in Fig. 5B, D, ATP was
now unable to prevent fast activation and rundown,
confirming a functional importance of R153/R154.
In addition, initial current densities [29.8 pA/pF
(ATP) vs. 29.4 pA/pF (ATP)] were identical, and
maximal current densities were slightly larger than wild
type. Reversion of the positive charges by mutating
arginine into glutamate (RR/EE) resulted in an 90%
reduction in both initial and maximal current sizes,
demonstrating that negative charges in this position
critically affect ion channel function. Charge reversion
also partially mimicked the current stabilizing effect of
ATP by reducing the percentage REM in the absence of
ATP to 70.5 compared to 45 for wild type (P0.5). To
further test that this region contains a functionally
relevant ATP binding site, we included a peptide con-
taining the sequence from aa 147 to 165 (see Fig. 5A)
together with ATP in the patch pipette. Figure 5C, E
shows that the peptide was indeed able to compete with
ATP and induce rundown. To test for direct binding of
ATP to this protein region, we expressed and purified
the protein fragment covering the ARD of wild-type and
RR/QP mutants and tested their ability to be retained by
ATP-agarose. Wild-type ARD is retained by ATP-agarose,
Figure 4. Stimulation of PKC counteracts ATP-dependent stabilization of currents. A) Normalized current density over time for
TRPV6b-expressing control cells (black trace) and cells that were pretreated for 1 h with 500 nM PMA (dark gray trace).
B) Quantification of rundown (%REM) after 20 min for recordings in A. C, D) Normalized current densities over time (C) and
quantification of %REM (D) as described in A, B for TRPV6a-expressing cells.
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Figure 5. Ank 3-Ank 4 linker region contains
essential amino acids for ATP binding. A) Linker
region between ankyrin repeats 3 and 4 contains
the first consensus site (S144, black circle) for
PKC-mediated phosphorylation. Serine 155 (punc-
tate gray circle) is a potential phosphorylation site
only in TRPV6a. Threonine 150 (light gray shade)
is the site most likely to be phosphorylated accord-
ing to the NetPhosK algorithm. Peptide sequence
used for competition is underscored. B) Normalized current density over time for transiently expressed wild-type and
R153Q/R154P mutants in the presence of 3.7 mM free ATP. C) Normalized current density over time for stable
TRPV6b-expressing cells recorded in the presence of 609 M free ATP (black trace), 609 M free ATP  2 mM
competing peptide encompassing sequence underscored in A (dark gray trace), or without added ATP (light gray
trace). D, E) Quantification of rundown at 10 min for transient cells (D) and at 20 min for stable cells (E). F) ATP-agarose
pulldown experiment with wild-type or RR/QP mutant fusion protein of the ARD (aa 42–266). Input (2% of total) or bound
His-tagged fusion proteins were detected by Western blot using an anti-HIS antibody. Binding was competed with 6 mM
ATP but not with 6 mM adenosine (ade).
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and binding can be competed for by free ATP or UTP
(data not shown), but not by adenosine (Fig. 5F). In
contrast, RR/QP-ARD showed a significant reduction in
binding to ATP-agarose (Fig. 5F). Together, these results
suggest that the ARD 3–4 region with residues R153/154
mediate binding of ATP’s negatively charged moieties
and is responsible for its physiological effects. Phosphor-
ylation at S144, and possibly at S155 in the case of
TRPV6a, may prevent binding either by charge hindrance
or by a conformational change.
If phosphorylation of TRPV6 mediates the PMA
effect, we should be able to define functionally
relevant phosphorylation sites by mutating the con-
sensus site serine or threonine residues. The first site,
S144, is solvent exposed (22) (Fig. 6A), and S144A
mutants were resistant to rundown in the presence of
PMA (Fig. 6B, C), confirming the hypothesis that
ATP binding may be sterically hindered by phosphor-
ylation at the ARD 3,4 linker region. The faster
current development of S144A mutants (ATP) is
partially due to transient expression (see Supplemen-
tal Fig. S1). Currents in the absence of ATP were
identical to wild type (%REM; Fig. 6C).
To test whether other PKC phosphorylation sites
are also involved, we mutated single sites detected by
the prosite algorithm (35) and investigated the ef-
fects of PMA. Figure 6A shows the relative location,
and Fig. 6D–F shows average current densities over
time for 3 additional mutants. Three other sites
(T150A, S318A, and T702A) showed clear PMA-
induced rundown (Fig. 6D, E, G). Mutating the dual
phosphorylation site T298A/T299A resulted in a
weaker effect of PMA, but mutation of the C-terminal
site T688A was as efficient as the S144A mutation in
blocking the PMA effect (Fig. 6F, G). All mutants
displayed comparable rundown to wild type in the
absence of added ATP (data not shown).We have also
confirmed ATP-mediated prevention of rundown for
mTRPV5 and for mTRPV6. Although other putative
PKC sites are conserved between species, T688 is not
a consensus site within mTRPV5, and PMA was
unable to oppose the effects of ATP in mTRPV5 (see
Supplemental Fig. S2C–F). These results point to-
ward a synergistic role of the C-terminal phosphory-
lation site in mediating the effect of PMA and raise
the possibility that a C-terminal region could also be
involved in binding of ATP.
Isozyme specificity
To address the specificity of the PMA effect, we
incubated TRPV6b cells with an inactive analog of
PMA, 4PDD. This inactive analog was unable to
mimic the effects of PMA (Fig. 7A, B), confirming a
likely effect on activation of PKCs. We tried to block
the effect of PMA by pretreatment with both BIS and
Go¨6983, inhibitors of classical PKCs, and then added
PMA for 1 h. Surprisingly, these inhibitors were
unable to prevent the effect of PMA on current
Figure 6. Mutational analysis of PKC phosphorylation sites. A) Schematic representation of putative PKC phosphorylation sites
as found by the Prosite algorithm. B) Normalized current density over time for TRPV6_S144A mutants with and without PMA
(500 nM for 1 h) treatment in the presence of ATP. C) Quantification of rundown for transiently expressed TRPV6 wild-type
and TRPV6 S144A mutants. D–F) Normalized current density over time for transiently expressed mutants T150A (D), S318A (E),
and T688A (F). G) Bar graph showing quantification of rundown in the presence of 3.7 mM free ATP with (gray) or without
(black) PMA preincubation.
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development (Fig. 7A, B). Because neither BIS nor
Go¨6983 has a defined IC50 for the PKCII isoform, we
tested whether Ro-31-8322, with an IC50 of 14 nM for
PKCII (36), was able to prevent PMA from counter-
acting the ATP effects. Figure 7A, B shows that
Ro-31-8322 was indeed able to suppress the effects of
PMA, suggesting that PMA exerts its effects through
activation of PKCII. Ro-31-8322 alone did not have
effects on ATP-modulated TRPV6b currents in the
absence of PMA (data not shown). One concern that
remained was that long incubation times were neces-
sary to see the effects of PMA, whereas translocation
of cPKCs happens within minutes. However, HEK293
cells express only low levels of endogenous PKCII protein
(37); therefore, we overexpressed GFP-tagged PKCII or
GFP-tagged PKC and tested whether PMA was now able
to exert its effects within minutes. Indeed, with expression
of PKCII, but not with overexpression of PKC, TRPV6
currents now showed PMA-induced rundown when
added to the bath solution without preincubation (Fig.
7C, D). Both PKC isoforms showed translocation to the
plasma membrane after stimulation with PMA (Fig. 7E
and data not shown). To test if PKCII expression is
found in similar tissue types as TRPV6, we checked
for its presence in human placenta cDNA (5) using
isoform-specific PCR primers and were indeed able
to amplify DNA of the correct size (Fig. 7F).
ATP binding sites
To screen for additional ATP binding sites, we created
fusion proteins (10xHIS at N-term) covering all intra-
cellular protein domains and tested their ability to be
retained by ATP-agarose. We found several additional
potential binding regions within TRPV6: although the
very N-terminal region of the protein containing ARD 1
and 2 (Supplemental Fig. S3B) was not retained by
ATP-agarose, thus demonstrating that the HIS tag
alone does not confer unspecific binding, the ARD
region showed weak binding (see also Fig. 5). The
N-terminal region between aa 267 and TM1 was also
retained (Supplemental Fig. S3D). Its sequence con-
tains a basic KKR region as well as a potential PH
domain and the dual phosphorylation site T298A/
T299A. The proximal region (aa 584-632) of the C-
terminal domain containing the TRP motif showed
binding that is not efficiently competed for by free
ATP, and thus not as specific (Supplemental Fig. S3E).
However, the distal region (aa 633 to 725; CT) is well
retained by ATP-agarose, and binding is effectively
Figure 7. PMA-mediated effects are PKC isoform specific. A) Normalized current density over time for TRPV6b-expressing cells
that were pretreated either for 1 h with PMA (dark blue) or 4--PDD (green) or for 30 min with 500 nM each of inhibitors
Go¨6983/BIS (light blue) or Ro-31-8220 (orange) and then with inhibitors and 500 nM PMA for 1 h. B) Percentage REM for PMA
and inhibitors. C) Normalized current densities recorded from TRPV6b stable cells with transient expression of GFP-PKCII or
GFP-PKC. D) Percentage REM with acute (10 min in bath) PMA treatment for TRPV6b (V6) cells alone or V6 cells transfected
with either GFP-PKCII or GFP-PKC. A–D) Internal solution with 3.7 mM free ATP. E) Fluorescent images from TRPV6b cells
expressing GFP-PKCII before and after PMA-stimulation. F) PKCII differs from PKCI by 162 specific C-terminal nucleotides.
These were amplified with II specific primers proportional to the amount of template (human placental cDNA or from
recombinant PKCII vector).
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competed for by free ATP (Supplemental Fig. S3F). We
also checked retention of the ARD region of rat TRPV1
that has been shown to bind ATP (21) (Supplemental
Fig. S3G). Considering that T688 is a potential phos-
phorylation site preventing ATP binding (see Fig. 6F, G
and Supplemental Fig. S2) and the finding that the
C-terminal fusion protein encompassing T688 is well
retained by ATP-agarose, we wanted to confirm binding
to ATP agarose for ARD and CT proteins under native
purification conditions. Because proteins containing
the N-terminal 10xHIS tag could be solubilized only
with urea, we constructed ARD and CT fusion proteins
with a C-terminal 6xHIS Tag (Supplemental Fig. S3H)
and repeated binding experiments after native purifi-
cation. ARD was retained by ATP-agarose with binding
efficiencies of 10% in several experiments (Coomas-
sie and Western blot), and CT showed binding efficien-
cies of 15%, comparable to the proteins purified in
the presence of urea. In addition, in vitro translated
full-length TRPV6 was retained by ATP-agarose in the
absence of ATP in the binding buffer, but significantly
less in the presence of ATP (data not shown).
Because mutations in individual phosphorylation
sites either in the N- or in the C-terminal region (S144,
T688) did not show rundown despite PMA incubation
and because both fusion proteins encompassing these
sites were also retained by ATP-agarose, we suggest a
model where ATP directly binds to TRPV6 and might
act as a stabilizing factor between the intracellular N
and C termini, with residues in both the N- and
C-terminal domains necessary for efficient binding in
the native protein (see model, Fig. 8). The Hill slope
of 4.8 as estimated from the dose response (Fig. 3D)
strengthens this model for a tetrameric channel.
Phosphorylation near the N- and C-terminal binding
sites destabilizes the protein and tags channels for
rundown.
DISCUSSION
Stringent regulation of Ca2 influx through TRPV6 is a
necessary requirement to avoid Ca2 overload. TRPV6
is inactivated by several Ca2-dependent pathways such
as regulation by calmodulin, breakdown of PIP2 and
probably constitutive exo- and endocytotic mechanisms
(38, 39). However, there are also Ca2-independent
mechanisms that lead to channel rundown. Our work
identifies ATP as an intracellular ligand that stabilizes
the channel and prevents rundown. Because both
absolute and normalized maximal current densities are
not significantly different within the recording time
with or without ATP, ATP does not seem to increase the
number of channels in the membrane, although it may
prevent the reduction of the number of channels that
could lead to rundown. The prevention of rundown
does not necessitate hydrolysis of ATP, shows nucleo-
tide specificity (although other phosphorylated nucle-
otides can partially substitute), and cannot be mimicked
by PIP2. Stabilization of current size shows an EC50 of
380 M free ATP. This value corresponds well with
physiological levels of free ATP and allows the channels to
respond to small decreases in ATP concentration to
prevent Ca2 overload while the Ca2-ATPases in the
plasma membrane (EC50 for ATP 0.1–1 M; see ref. 40)
are still functional. We identified R153 and R154 as
being essential for mediating the functional ATP effect.
Disruption of this site both by mutagenesis or compe-
tition by a peptide resembling this linker sequence
disables ATP from decreasing current increments and
preventing rundown. Because the RR/QP mutants still
show normal currents in the absence of ATP, these
mutations did not disturb essential functions not re-
lated to the ATP effect. However, charge reversion at
this site by creation of RR/EE mutant channels severely
reduced current size, which mimics to some extent
adding negative charges from ATP’s phosphate moi-
eties, but is unable to substitute the adenosine moiety
of ATP, which may have its own binding site (see Figs.
3A, B and 8). Evidence from ATP-agarose pulldown
experiments support a hypothesis that ATP interacts
with this N-terminal ARD domain through its negatively
charged phosphate groups. Because Phelps et al. (22)
did not find retention of mTRPV6 ARD by ATP-
agarose, we also expressed and purified ARD and CT of
hTRPV6 with a similar C-terminal 6xHIS tag under
native conditions. ARD still showed binding to ATP-
agarose, indicating that species differences or storage
conditions (10 mM EDTA, 2.5 mM 2-mercaptoethanol;
see ref. 22) may account for differences in binding. The
effects of ATP on both current stabilization and activa-
Figure 8. Model of regulatory mechanisms on TRPV6 by ATP
and phosphorylation. To simplify graph, only one pore-
forming subunit is represented. In the absence of ATP, the
channel is prone to both Ca2-dependent (calmodulin) and
Ca2-independent regulation and rundown. Sufficient ATP
stabilizes N and C termini and prevents channel rundown.
Phosphorylation hinders ATP binding and thus reduces its
stabilizing effect.
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tion kinetics were disrupted when TRPV6 cells (stable
or transient expression) were incubated with PMA. This
effect is PKC specific and requires activation of PKCII,
a PKC isoform that is not strongly expressed in HEK293
cells but is present together with TRPV6 in placenta.
Overexpression of PKCII, but not of PKC, obliterates
the need for PMA preincubation. The results obtained
from mutating individual phosphorylation sites argue
for a direct effect, where phosphorylation of TRPV6
might hinder binding of ATP. Because both the N-
terminal and the distal TRPV6 C-terminal fusion pro-
teins are retained by ATP-agarose and because mu-
tagenesis of putative phosphorylation sites within
these domains (S144A and T688A) are able to sup-
press the PMA effect, we propose a synergistic effect
of both binding sites. ATP might form a bridge
between both domains and thereby alter channel
properties (Fig. 8), leading to slowed current devel-
opment and reduced rundown. To fully understand
the dual effects of ATP, single-channel analyses will
be necessary. Low-resolution freeze fracture data
obtained for TRPV1 (41) may suggest an interaction
between N- and C-terminal regions. Because a mu-
tant that lacks the C-terminal calmodulin binding site
of TRPV6 still shows an effect of ATP on rundown
(data not shown), the C-terminal ATP binding site
does not overlap with the calmodulin binding site,
unlike the multiligand binding site of TRPV1 (21).
A small drop in cellular-free ATP levels (i.e., by a 1–2
mM increase in Mg2; see ref. 42) leads to channels less
stable and more prone to both Ca2-dependent and
Ca2-independent rundown phenomena and thus a
reduction in overall Ca2 influx. Activation of PKCII
prevents stabilization by ATP, and channels show more
rundown and Ca2-dependent inactivation. The up-
stream GPCR that activates PKCII in vivo may thus be
involved in feedback regulation when sufficient Ca2
has been taken up by TRPV6 and may also be respon-
sible for conferring an allele-specific advantage. It will
be interesting to analyze if and how both kinases
regulate the native channels. Unfortunately, these
studies are hampered by the difficulty in obtaining
human cells in which native TRPV6 currents can be
measured.
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